Literature DB >> 15014004

NSAIDs for the chemoprevention of oral cancer: promise or pessimism?: Commentary re J. L. Mulshine et al., randomized, double-blind, placebo-controlled, phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin. Cancer Res., 10: 1565-1573, 2004.

Susan Goodin1, Steven J Shiff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15014004     DOI： 10.1158/1078-0432.ccr-0003-4

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  Decreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugs.

Authors:  Neda Ahmadi; Radoslav Goldman; Françoise Seillier-Moiseiwitsch; Anne-Michelle Noone; Ourania Kosti; Bruce J Davidson
Journal:  Int J Otolaryngol       Date:  2010-06-03

2.  Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study.

Authors:  S Friis; A Poulsen; L Pedersen; J A Baron; H T Sørensen
Journal:  Br J Cancer       Date:  2006-07-25       Impact factor: 7.640

Review 3.  Biomarkers and chemopreventives in oral carcinogenesis and its prevention.

Authors:  Sonalee Shah; Manpreet Kaur
Journal:  J Oral Maxillofac Pathol       Date:  2014-01

4.  Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.

Authors:  T V Macfarlane; K Lefevre; M C Watson
Journal:  Br J Cancer       Date:  2014-09-11       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.